Write For Us

US secures 300 million doses of potential AstraZeneca COVID-19 vaccine

E-Commerce Solutions SEO Solutions Marketing Solutions
145 Views
Published
The United States has secured almost a third of the first 1 billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as world powers scramble for medicines to get their economies back to work.

While not yet proven to be effective against the coronavirus, vaccines are seen by world leaders as the only real way to restart their stalled economies, and even to get an edge over global competitors.

After President Donald Trump demanded a vaccine, the US Department of Health and Human Services (HHS) agreed to provide up to $1.2 billion to accelerate British drugmaker AstraZeneca's vaccine development and secure 300 million doses for the United States.
Category
TV Saluran - TV Channel
Sign in or sign up to post comments.
Be the first to comment